Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Daily dosing or long-acting injectables may be better options for those who have spontaneous sex.
New international report describes the risk factors and outcomes of more than 130 women and nonbinary people.
Canada’s new blood screening policy will not focus on sexual orientation. How does it compare with U.K. and U.S. rules?
What this means for women’s HIV acquisition rates is unclear.
Abnormal anal screening results are common, but they often do not to lead to invasive cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.